NCT07217795 Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
| NCT ID | NCT07217795 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rhode Island |
| Condition | Alcohol Use Disorder (AUD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-11-30 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-11-30 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
Eligibility Criteria
Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria Aim 1: Providers -Not meeting inclusion criteria Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals * Not meeting inclusion criteria OR any of the following: * Reporting current mental health treatment ≥1 day/month * Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment) * Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment * Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar) * Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R) * Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM) * Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS) * Currently legally mandated to attend treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07217795 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder (AUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217795 currently recruiting?
Yes, NCT07217795 is actively recruiting participants. Contact the research team at jillian.scheer@uri.edu for enrollment information.
Where is the NCT07217795 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT07217795 clinical trial?
NCT07217795 is sponsored by University of Rhode Island. The trial plans to enroll 80 participants.